Effect of experimental parameters on the in vitro release kinetics of transforming growth factor beta1 from coral particles.
Coral bone graft substitutes have been supplemented in the past with growth factors to further enhance bone regeneration in defects. Little is known, however, on the dynamics of protein release from coral. Coral particles were studied for their ability to release transforming growth factor beta 1 (TGF-beta1) in vitro, under different adsorption conditions. Adsorption of TGF-beta1 (0.05 microg/mL) on coral particles (<80 microm or 300-450 microm) after 24 h of incubation was high, regardless of conditions. TGF-beta1 release kinetics in an artificial bone fluid followed a specific profile: an initial 1-h protein burst, followed by a decreasing release during the next 24 h at which time the release increased again to reach a constant rate until the end of the 2-week study. The protein release rate appeared mainly to depend upon the diffusion of TGF-beta1. TGF-beta1 release from coral particles was enhanced in the presence of bovine serum albumin (BSA) compared to the release in the presence of gelatin, and was dependent on the pH of adsorption. The highest total TGF-beta1 release was obtained when adsorption occurred with BSA at pH 7.4 (82 +/- 3%), while the lowest release was observed when adsorption was done in the presence of gelatin at pH 11 (38 +/- 1%). TGF-beta1 release was also found to vary with particle size, higher release being obtained with the smaller particles. These results suggest that coral particles could be used as a delivery system for growth factors, and that the release rate may be modulated through modification of the adsorption conditions and coral particle size.
Demers
Caroline N
CN
BBRG, Department of Mechanical Engineering, Ecole Polytechnique, P.O. Box 6079, Station Centre-ville, Montréal, QC H3C 3A7, Canada. cndemers@hotmail.com
Tabrizian
Maryam
M
Petit
Alain
A
Hamdy
Reggie C
RC
Yahia
L'Hocine
L
D000327:Adsorption; D000818:Animals; D037421:Anthozoa / Q000378:metabolism*; D001672:Biocompatible Materials; D016025:Bone Transplantation / Q000379:methods; D004337:Drug Carriers; D004343:Drug Implants / Q000493:pharmacokinetics; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D010316:Particle Size; D016212:Transforming Growth Factor beta / Q000493:pharmacokinetics*; D053773:Transforming Growth Factor beta1
D001672:Biocompatible Materials; D004337:Drug Carriers; D004343:Drug Implants; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1